Noting this press release as it shines light into the foothold AI is gaining in major sectors, in this case, pharmaceuticals: “For over a decade, Moderna has been at the intersection of science, technology and health. Since our beginnings, we’ve leveraged the power of machine learning to support our mission to develop transformative mRNA medicines. The data platform we’ve built over our history helps fuel innovation and positions us well to capitalize on next-generation AI tools. With an ambitious plan to launch multiple products in the next few years, we see AI as a key component to our ability to scale and maximize our impact on patients. This morning, we announced our ongoing collaboration with OpenAI to co-innovate with a shared vision of AI’s immense potential in the future of business and healthcare. From launching mChat in 2023, our own instance of ChatGPT built on top of OpenAI’s API, to recently deploying OpenAI’s ChatGPT Enterprise across our various business functions, this collaboration will help ensure every employee at Moderna has a purpose-built AI assistant to augment their work with personalized support. To learn more, read the case study about how we’re bringing AI to life across our clinical development, legal and corporate brand teams…”

See also Growing Evidence Shows Importance of AI for Healthcare